This prospective, observational study is designed to investigate clinical outcomes and collect patient feedback on the use of Wellinks, an integrated virtual chronic obstructive pulmonary disease (COPD) management solution, for patients recently discharged from the hospital due to an acute exacerbation of their COPD.
Wellinks, an integrated virtual COPD management solution consists of a combination of health coaching, Bluetooth-connected devices, collection of patient-reported symptoms and medication use, and virtual pulmonary rehabilitation, all centralized by the use of a mobile-phone application (mobile app) downloaded onto a study participant's iOS (iPhone) or Android device. The clinical objectives of this study are to determine whether utilization of Wellinks can reduce the rate of hospital readmissions due to a COPD exacerbation for patients recently discharged from the hospital. The nonclinical objectives of this study are to describe the experience of study participants using Wellinks through the assessment of engagement with the components of Wellinks, as well as by participant-reported satisfaction and perceived value (e.g., willingness to pay). Qualitative feedback on the features and functionality of Wellinks will be solicited.
Study Type
OBSERVATIONAL
Enrollment
150
30-day post-discharge period: virtual respiratory therapist sessions twice per week with synchronous virtual pulmonary rehabilitation and educational materials; at-home use of connected spirometer and pulse oximeter; at-home use of mobile app. 12-week intensive period: virtual health coaching sessions once every two weeks; asynchronous virtual pulmonary rehabilitation program; ongoing access to connected devices (spirometer and pulse oximeter) and mobile app.
Hartford Hospital
Hartford, Connecticut, United States
RECRUITINGHospital readmission rate (all-cause)
Rate of all-cause hospital readmission
Time frame: 30-days post-discharge from index event
Hospital readmission rate (all-cause)
Rate of all-cause hospital readmission
Time frame: 60-days post-discharge from index event
Hospital readmission rate (all-cause)
Rate of all-cause hospital readmission
Time frame: 90-days post-discharge from index event
Hospital readmission rate (COPD-related)
Rate of COPD-related hospital readmission
Time frame: 30-days post-discharge from index event
Hospital readmission rate (COPD-related)
Rate of COPD-related hospital readmission
Time frame: 60-days post-discharge from index event
Hospital readmission rate (COPD-related)
Rate of COPD-related hospital readmission
Time frame: 90-days post-discharge from index event
COPD Assessment Test
Assess quality-of-life impact of COPD
Time frame: Change from baseline to day 30 (end of post-discharge intervention phase) and to week 16 (end of study)
Exercise capacity: 30-second sit-to-stand
Assess exercise capacity
Time frame: Change from baseline to day 30 (end of post-discharge intervention phase) and to week 16 (end of study)
Modified Medical Research Council Dyspnea Index (mMRC)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Assess shortness of breath and impact on daily activities
Time frame: Change from baseline to day 30 (end of post-discharge intervention phase) and to week 16 (end of study)
Wellinks App Engagement
Frequency of use of the mobile app throughout the study period
Time frame: 16 weeks
Wellinks Device Engagement
Frequency of use of the connected devices throughout the study period
Time frame: 16 weeks
Wellinks Session Engagement
Participation rate in scheduled respiratory therapist and health coaching sessions
Time frame: 16 weeks
Patient Satisfaction (Net Promoter Score)
Net promoter score from asking, "How likely is it that you would recommend Wellinks to a friend or colleague?"
Time frame: 16 weeks